The financials
Hims & Hers Health, Inc. by the numbers
Hims & Hers Health, Inc. (HIMS) reported revenue of $753M in Q2 2026 (quarter ended June 30, 2026), up 38% from the same quarter a year earlier. That came with a gross margin of 64% and net loss of $86M. For the full year FY2025, revenue was $2.35B (+59% year on year) and net income $128M.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $753M | $545M | +38% |
| Gross profit | $481M | $416M | +16% |
| Operating income | −$97M | $27M | to a loss |
| Net income | −$86M | $43M | to a loss |
| Diluted EPS | −$0.37 | $0.17 | to a loss |
Drug Manufacturers - Specialty & Generic
Ranks #16 of 28 by Smart Score